Protective Effects and Molecular Mechanisms of Sini Tang in Treating Ponatinib-induced Heart Failure in Mice
10.13422/j.cnki.syfjx.20260504
- VernacularTitle:四逆汤对帕纳替尼导致小鼠心力衰竭的保护作用及分子机制探析
- Author:
Xi FENG
1
;
Yanfen CHENG
2
;
Pei WANG
1
;
Jingjing LI
3
;
Sha LI
1
;
Juehan ZHOU
1
;
Ying LONG
1
;
Shengjun LIU
1
;
Yuqing ZHOU
1
;
Shuhan LI
1
;
Chaomei FU
1
;
Shu FU
1
Author Information
1. Chinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province, School of Pharmacy/School of Modern Chinese Medicine Industry, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
2. School of Preclinical Medicine, Chengdu University, Chengdu 610106, China
3. Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong 999077, China
- Publication Type:Journal Article
- Keywords:
Sini Tang;
heart failure;
ponatinib;
transcriptomics;
molecular docking;
mitogen-activated protein kinase (MAPK) pathway;
cardiomyocyte apoptosis
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2026;32(24):14-24
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the protective effect and molecular mechanisms of the classical prescription Sini Tang (SNT) in treating heart failure (HF) induced by ponatinib (PNT), a third-generation multi-target tyrosine kinase inhibitor used for treating hematological malignancies, based on the traditional efficacy of warming the middle to dispel cold and restoring Yang to save from collapse. MethodsThe HF model in mice was established by gavage of PNT, and SNT was used for intervention. Fifty-four mice were randomized into a control group, a model group, high-dose (10.4 g·kg-1), medium-dose (5.2 g·kg-1), and low-dose (2.6 g·kg-1) SNT groups, and a captopril (15 mg·kg-1) group. A high-resolution small animal ultrasound imaging system was used to evaluate the cardiac structure and function of mice. Transcriptomics combined with network pharmacology was utilized to explore the pathways involved in the SNT treatment of PNT-induced HF. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was adopted to observe the apoptosis of mouse cardiomyocytes. Immunohistochemistry was employed to detect the expression of cleaved cysteinyl aspartate-specific proteinase-3 (cleaved Caspase-3) in mouse cardiomyocytes. The serum levels of brain natriuretic peptide (BNP), cardiac troponin T (cTnT), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and malondialdehyde (MDA) in mice were determined by enzyme-linked immunosorbent assay (ELISA). Western blot was conducted to determine the expression levels of mitogen-activated protein kinase (MAPK) signaling pathway-related proteins, including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), p38 MAPK, Fos proto-oncogene (c-FOS), and their phosphorylated forms in the cardiac tissue. ResultsCompared with the model group, SNT interventions at all doses increased LVEF and LVFS (P<0.01) and reduced the left ventricular end-systolic diameter (LVIDs) (P<0.05, P<0.01). Furthermore, SNT decreased the heart index (P<0.05, P<0.01) and ameliorated histopathological lesions in the cardiac tissue. Integrated transcriptomic and network pharmacology analyses revealed that the pivotal mechanisms underlying the protective effects of SNT against PNT-induced HF were closely associated with cardiomyocyte apoptosis, as well as the MAPK and TNF signaling pathways. SNT treatment inhibited PNT-induced cardiomyocyte apoptosis and the expression of cleaved Caspase-3 in the cardiac tissue (P<0.05, P<0.01). Furthermore, it reduced the serum levels of BNP, cTnT, TNF-α, IL-6, and MDA (P<0.05, P<0.01), and down-regulated the relative protein levels of MAPK pathway molecules, including p-JNK/JNK, p-ERK/ERK, p-p38 MAPK/p38 MAPK, and c-FOS, in the cardiac tissue (P<0.05, P<0.01). ConclusionSNT intervention can regulate the MAPK signaling pathway, inhibit myocardial injury and cardiomyocyte apoptosis, and alleviate oxidative stress and inflammatory responses to exert the cardioprotective effect, thereby effectively ameliorating PNT-induced HF in mice. This study provides a reference for traditional Chinese medicine in alleviating the cardiotoxic effects of chemotherapeutic drugs and lays a foundation for the in-depth development and novel clinical application of classical prescriptions.